211 related articles for article (PubMed ID: 33660353)
1. Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.
Quesada AE; Zhang Y; Ptashkin R; Ho C; Horwitz S; Benayed R; Dogan A; Arcila ME
Breast J; 2021 Apr; 27(4):314-321. PubMed ID: 33660353
[TBL] [Abstract][Full Text] [Related]
2. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Oishi N; Miranda RN; Feldman AL
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
[TBL] [Abstract][Full Text] [Related]
3. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
[TBL] [Abstract][Full Text] [Related]
5. Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
DeCoster RC; Clemens MW; Di Napoli A; Lynch EB; Bonaroti AR; Rinker BD; Butterfield TA; Vasconez HC
Plast Reconstr Surg; 2021 Jan; 147(1):30e-41e. PubMed ID: 33370049
[TBL] [Abstract][Full Text] [Related]
6. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
7. ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.
Parkhi M; Bal A; Das A; Kashyap D; Bhardwaj S; Prakash G; Malhotra P
Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):648-656. PubMed ID: 33901030
[TBL] [Abstract][Full Text] [Related]
8. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
Laurent C; Nicolae A; Laurent C; Le Bras F; Haioun C; Fataccioli V; Amara N; Adélaïde J; Guille A; Schiano JM; Tesson B; Traverse-Glehen A; Chenard MP; Mescam L; Moreau A; Chassagne-Clement C; Somja J; Escudié F; André M; Martin N; Lacroix L; Lemonnier F; Hamy AS; Reyal F; Bannier M; Oberic L; Prade N; Frénois FX; Beldi-Ferchiou A; Delfau-Larue MH; Bouabdallah R; Birnbaum D; Brousset P; Xerri L; Gaulard P
Blood; 2020 Jan; 135(5):360-370. PubMed ID: 31774495
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma.
Oishi N; Hundal T; Phillips JL; Dasari S; Hu G; Viswanatha DS; He R; Mai M; Jacobs HK; Ahmed NH; Syrbu SI; Salama Y; Chapman JR; Vega F; Sidhu J; Bennani NN; Epstein AL; Medeiros JL; Clemens MW; Miranda RN; Feldman AL
Haematologica; 2021 Jun; 106(6):1714-1724. PubMed ID: 32414854
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.
Blombery P; Thompson ER; Jones K; Arnau GM; Lade S; Markham JF; Li J; Deva A; Johnstone RW; Khot A; Prince HM; Westerman D
Haematologica; 2016 Sep; 101(9):e387-90. PubMed ID: 27198716
[No Abstract] [Full Text] [Related]
11. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
12. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P; Thompson ER; Prince HM
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
[TBL] [Abstract][Full Text] [Related]
13. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
14. Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
[TBL] [Abstract][Full Text] [Related]
15. Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.
Di Napoli A; Jain P; Duranti E; Margolskee E; Arancio W; Facchetti F; Alobeid B; Santanelli di Pompeo F; Mansukhani M; Bhagat G
Br J Haematol; 2018 Mar; 180(5):741-744. PubMed ID: 27859003
[No Abstract] [Full Text] [Related]
16. Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Rondón-Lagos M; Rangel N; Camargo-Villalba G; Forero-Castro M
Eur J Surg Oncol; 2021 May; 47(5):942-951. PubMed ID: 33158639
[TBL] [Abstract][Full Text] [Related]
17. ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas.
Pina-Oviedo S; Ortiz-Hidalgo C; Carballo-Zarate AA; Zarate-Osorno A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572893
[TBL] [Abstract][Full Text] [Related]
18. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract][Full Text] [Related]
19. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
[TBL] [Abstract][Full Text] [Related]
20. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
